Biaxin, Clarithromycin News

News on Biaxin, Clarithromycin (generic) continually updated from thousands of sources around the net.

Saturday Feb 4 | News Observer

Chapel Hill-based Cempra's IPO raises nearly $48 million

Pharmaceutical company Cempra on Friday became the first Triangle company to complete an initial public offering of stock in 10 months, raising nearly $48 million.

Comment?

Mon Jan 16, 2012

News Observer

Cempra files expected IPO price

Cempra Pharmaceuticals expects the offering price for its planned IPO to be between $11 and $13, the Chapel Hill company reported in a regulatory filing last week.

Comment?

Wed Jan 11, 2012

Business Wire

Research and Markets: Flooded by Generics ENT Disorders Therapeutics Market to Witness Meager Growth

GBI Research, the leading business intelligence provider, has released its latest research, ENT Disorders Market to 2017- Cephalosporins, Quinolones and Macrolides to Replace Older Therapies Due to Anti-Bacterial Resistance , which provides in-depth analysis of the unmet needs, drivers and barriers that affect the global ENT disorders therapeutics ... (more)

Comment?

Thu Dec 01, 2011

Florida Today

Senior Consult: Heed warnings about Simvastatin

In June, the FDA recommended limiting the use of the highest approved dose of the cholesterol-lowering medication simvastatin.

Comment?